These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2065763)

  • 1. Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo.
    Sánchez V; Goberna R; Calvo JR
    Experientia; 1991 Jun; 47(6):625-6. PubMed ID: 2065763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulatory effect of vasoactive intestinal peptide on glycogenolysis and gluconeogenesis in isolated rat hepatocytes: antagonism by insulin.
    Felíu JE; Mojena M; Silvestre RA; Monge L; Marco J
    Endocrinology; 1983 Jun; 112(6):2120-7. PubMed ID: 6343059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Tatemoto K; Efendić S
    Endocrinology; 1983 Apr; 112(4):1469-73. PubMed ID: 6339205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vasoactive intestinal polypeptide on glycogen metabolism in rat hepatocytes.
    Wood CL; Blum JJ
    Am J Physiol; 1982 Apr; 242(4):E262-72. PubMed ID: 6801998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.
    Matsumura M; Akiyoshi H; Fujii S
    J Biochem; 1977 Oct; 82(4):1073-6. PubMed ID: 924981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of vasoactive intestinal peptide on glycogenolysis in cultured liver cells.
    Matsumura M; Akiyoshi H; Saito S; Mori H
    Endocrinol Jpn; 1979 Apr; 26(2):233-7. PubMed ID: 477614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogenolytic effect of pancreastatin in the rat.
    Sanchez V; Calvo JR; Goberna R
    Biosci Rep; 1990 Feb; 10(1):87-91. PubMed ID: 2187544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permissive effect of VIP on the hyperglycemic response induced by 2-deoxy-D-glucose.
    Shimizu K; Hibino H; Komenami N; Nagai N; Nagai K; Nakagawa H
    Neurosci Lett; 1994 Jul; 175(1-2):157-60. PubMed ID: 7970200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide (VIP) stimulates fibrinolytic system in the rat.
    Hagiwara M; Hongo K; Morikawa T
    Jpn J Pharmacol; 1990 Sep; 54(1):86-8. PubMed ID: 2273652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of VIP and forskolin on alanine metabolism in isolated hepatocytes.
    Leiser J; Blum JJ
    FEBS Lett; 1984 Aug; 173(2):407-13. PubMed ID: 6540208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition.
    Sorg O; Magistretti PJ
    J Neurosci; 1992 Dec; 12(12):4923-31. PubMed ID: 1334506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal polypeptide-sensitive cyclic adenosine monophosphate generating system in the rat portal vein.
    Amenta D; Iacopino L; Amenta F
    Arch Int Pharmacodyn Ther; 1988; 291():88-95. PubMed ID: 2835024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glycogenolysis in the liver of the newborn rat in vivo. Inhibitory effect of glucose.
    Martín A; Caldés T; Benito M; Medina JM
    Biochim Biophys Acta; 1981 Feb; 672(3):262-7. PubMed ID: 7011419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nickel-induced hyperglycaemia: the role of insulin and glucagon.
    Cartañà J; Arola L
    Toxicology; 1992; 71(1-2):181-92. PubMed ID: 1729765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo.
    Sánchez-Margalet V; Calvo JR; Goberna R
    Horm Metab Res; 1992 Oct; 24(10):455-7. PubMed ID: 1464408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal glucose infusion increases hepatic glycogen deposition in conscious unrestrained rats.
    Cardin S; Emshwiller M; Jackson PA; Snead WL; Hastings J; Edgerton DS; Cherrington AD
    J Appl Physiol (1985); 1999 Oct; 87(4):1470-5. PubMed ID: 10517780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opposite effects of central and peripheral vasoactive intestinal polypeptide on blood pressure in rats.
    Casto R; Phillips MI
    Neurosci Lett; 1983 Jul; 38(2):169-73. PubMed ID: 6621937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of [Asu1 . 7]-eel calcitonin on glucagon-induced glycogenolysis in perfused rat liver.
    Mine T; Kimura S; Ogata E
    Horm Metab Res; 1983 Mar; 15(3):139-43. PubMed ID: 6303930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal polypeptide induces glycogenolysis in mouse cortical slices: a possible regulatory mechanism for the local control of energy metabolism.
    Magistretti PJ; Morrison JH; Shoemaker WJ; Sapin V; Bloom FE
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6535-9. PubMed ID: 6118864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the route of glucose administration on hepatic glycogen repletion.
    Shulman GI; Rossetti L
    Am J Physiol; 1989 Nov; 257(5 Pt 1):E681-5. PubMed ID: 2688436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.